FibroBiologics FBLG
NASDAQ FBLG
$1.02 +0.02 (+2.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

FibroBiologics (FBLG) Change in Receivables (2023)

Updated

FibroBiologics' Change in Receivables came in at $275,000 for Q1 2023.

Analysis

FibroBiologics (FBLG) Change in Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.37 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 FibroBiologics 6.40 Mn -8.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 275,000.00
API Access

FibroBiologics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=FBLG&period=max&api_key=YOUR_API_KEY